Globus Medical ROE 2010-2024 | GMED

Current and historical return on equity (ROE) values for Globus Medical (GMED) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Globus Medical ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-03-31 $0.07B $3.92B 1.90%
2023-12-31 $0.12B $4.00B 4.07%
2023-09-30 $0.16B $4.19B 6.36%
2023-06-30 $0.20B $1.99B 10.87%
2023-03-31 $0.20B $1.92B 11.13%
2022-12-31 $0.19B $1.85B 10.71%
2022-09-30 $0.16B $1.76B 8.87%
2022-06-30 $0.16B $1.70B 8.93%
2022-03-31 $0.14B $1.79B 8.25%
2021-12-31 $0.15B $1.74B 8.95%
2021-09-30 $0.19B $1.72B 11.64%
2021-06-30 $0.18B $1.64B 12.02%
2021-03-31 $0.12B $1.56B 8.31%
2020-12-31 $0.10B $1.51B 7.26%
2020-09-30 $0.10B $1.42B 6.89%
2020-06-30 $0.09B $1.34B 6.54%
2020-03-31 $0.15B $1.36B 10.98%
2019-12-31 $0.16B $1.40B 11.77%
2019-09-30 $0.15B $1.34B 11.56%
2019-06-30 $0.14B $1.29B 11.79%
2019-03-31 $0.15B $1.24B 12.87%
2018-12-31 $0.16B $1.19B 14.11%
2018-09-30 $0.14B $1.14B 13.61%
2018-06-30 $0.14B $1.10B 13.41%
2018-03-31 $0.12B $1.03B 12.41%
2017-12-31 $0.11B $0.97B 11.75%
2017-09-30 $0.11B $0.94B 12.20%
2017-06-30 $0.11B $0.91B 12.65%
2017-03-31 $0.11B $0.87B 12.76%
2016-12-31 $0.10B $0.83B 13.12%
2016-09-30 $0.12B $0.81B 15.46%
2016-06-30 $0.12B $0.78B 16.18%
2016-03-31 $0.12B $0.75B 16.68%
2015-12-31 $0.11B $0.72B 17.08%
2015-09-30 $0.10B $0.67B 16.38%
2015-06-30 $0.10B $0.64B 16.69%
2015-03-31 $0.10B $0.61B 17.01%
2014-12-31 $0.09B $0.59B 17.15%
2014-09-30 $0.09B $0.55B 16.73%
2014-06-30 $0.08B $0.53B 17.03%
2014-03-31 $0.07B $0.50B 14.97%
2013-12-31 $0.07B $0.47B 15.54%
2013-09-30 $0.07B $0.45B 16.34%
2013-06-30 $0.06B $0.42B 16.19%
2013-03-31 $0.08B $0.41B 20.53%
2012-12-31 $0.07B $0.39B 21.53%
2012-09-30 $0.07B $0.36B 21.10%
2012-06-30 $0.07B $0.32B 30.02%
2012-03-31 $0.06B $0.30B 42.47%
2011-12-31 $0.06B $0.28B 79.43%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.002B $1.568B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $225.258B 27.30
Intuitive Surgical (ISRG) United States $142.628B 85.92
Edwards Lifesciences (EW) United States $54.439B 35.43
DexCom (DXCM) United States $52.033B 78.82
Alcon (ALC) Switzerland $43.738B 31.34
IDEXX Laboratories (IDXX) United States $42.817B 50.19
IQVIA Holdings (IQV) United States $41.793B 24.25
STERIS (STE) Ireland $22.787B 26.63
Waters (WAT) United States $20.860B 30.66
SONOVA HOLDING (SONVY) Switzerland $18.415B 0.00
Hologic (HOLX) United States $17.398B 19.47
Fresenius Medical Care AG KGaA (FMS) Germany $12.570B 14.67
ShockWave Medical (SWAV) United States $12.376B 77.02
Sysmex ADR (SSMXY) Japan $10.888B 34.15
Teleflex (TFX) United States $10.032B 15.61
Penumbra (PEN) United States $7.762B 88.21
Masimo (MASI) United States $6.610B 38.08
Glaukos (GKOS) United States $5.466B 0.00
TransMedics (TMDX) United States $4.559B 432.56
Integer Holdings (ITGR) United States $4.064B 24.56
PROCEPT BioRobotics (PRCT) United States $3.533B 0.00
LivaNova (LIVN) United Kingdom $3.279B 19.47
Tandem Diabetes Care (TNDM) United States $3.186B 0.00
Elekta AB (EKTAY) Sweden $3.019B 20.71
Inari Medical (NARI) United States $2.658B 0.00
Nihon Kohden (NHNKY) Japan $2.488B 21.05
RxSight (RXST) United States $2.307B 0.00
Integra LifeSciences Holdings (IART) United States $2.158B 9.41
Veracyte (VCYT) United States $1.665B 0.00
Alphatec Holdings (ATEC) United States $1.494B 0.00
Artivion (AORT) United States $0.978B 93.84
AVANOS MEDICAL, INC (AVNS) United States $0.931B 18.12
OPKO Health (OPK) United States $0.906B 0.00
Silk Road Medical (SILK) United States $0.869B 0.00
OrthoPediatrics (KIDS) United States $0.785B 0.00
Mesa Laboratories (MLAB) United States $0.639B 21.70
Paragon 28 (FNA) United States $0.620B 0.00
SiBone (SIBN) United States $0.579B 0.00
IRadimed (IRMD) United States $0.559B 31.28
ORTHOFIX MEDICAL INC (OFIX) United States $0.543B 0.00
Pulse Biosciences (PLSE) United States $0.537B 0.00
Pacific Biosciences Of California (PACB) United States $0.498B 0.00
Nevro (NVRO) United States $0.366B 0.00
Treace Medical Concepts (TMCI) United States $0.308B 0.00
Tactile Systems Technology (TCMD) United States $0.305B 10.44
Sight Sciences (SGHT) United States $0.272B 0.00
AxoGen (AXGN) United States $0.266B 0.00
AngioDynamics (ANGO) United States $0.235B 0.00
NeuroPace (NPCE) United States $0.229B 0.00
Delcath Systems (DCTH) United States $0.225B 0.00
908 Devices (MASS) United States $0.223B 0.00
EDAP TMS S.A (EDAP) France $0.223B 0.00
Atossa Genetics (ATOS) United States $0.205B 0.00
Inogen (INGN) United States $0.203B 0.00
Alpha Tau Medical (DRTS) Israel $0.189B 0.00
CVRx (CVRX) United States $0.179B 0.00
ClearPoint Neuro (CLPT) United States $0.166B 0.00
Semler Scientific (SMLR) United States $0.166B 8.44
Accuray (ARAY) United States $0.151B 0.00
Spectral Diagnostics (EDTXF) Canada $0.103B 0.00
Yubo Biotech (YBGJ) China $0.100B 0.00
KORU Medical Systems (KRMD) United States $0.097B 0.00
Sensus Healthcare (SRTS) United States $0.097B 20.48
Neuronetics (STIM) United States $0.073B 0.00
EnVVeno Medical (NVNO) United States $0.065B 0.00
Hyperfine (HYPR) United States $0.064B 0.00
Monogram Orthopaedics (MGRM) United States $0.063B 0.00
Envoy Medical (COCH) United States $0.060B 0.00
InspireMD (NSPR) Israel $0.058B 0.00
DarioHealth (DRIO) United States $0.054B 0.00
Vicarious Surgical (RBOT) United States $0.052B 0.00
SEP Acquisition (SEPA) United States $0.052B 0.00
Lucid Diagnostics (LUCD) United States $0.047B 0.00
LENSAR (LNSR) United States $0.046B 0.00
ReWalk Robotics (LFWD) Israel $0.044B 0.00
Autonomix Medical (AMIX) United States $0.042B 0.00
Precision Optics (POCI) United States $0.040B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
Pixie Dust Technologies (PXDT) Japan $0.035B 0.00
Aspira Women's Health (AWH) United States $0.034B 0.00
Spectral AI (MDAI) United States $0.031B 0.00
T2 Biosystems (TTOO) United States $0.030B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.024B 0.00
Accelerate Diagnostics (AXDX) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.023B 0.00
QT Imaging Holdings (QTI) United States $0.020B 0.00
PAVmed (PAVM) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.014B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.011B 0.00
Avinger (AVGR) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00